Structure–Activity Relationship of the Dimeric and Oligomeric Forms of a Cytotoxic Biotherapeutic Based on Diphtheria Toxin

Protein aggregation is a well-recognized problem in industrial preparation, including biotherapeutics. These low-energy states constantly compete with a native-like conformation, which is more pronounced in the case of macromolecules of low stability in the solution. A better understanding of the st...

Full description

Bibliographic Details
Main Authors: Marcin Mielecki, Marcin Ziemniak, Magdalena Ozga, Radosław Borowski, Jarosław Antosik, Angelika Kaczyńska, Beata Pająk
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/12/8/1111
_version_ 1827600616273215488
author Marcin Mielecki
Marcin Ziemniak
Magdalena Ozga
Radosław Borowski
Jarosław Antosik
Angelika Kaczyńska
Beata Pająk
author_facet Marcin Mielecki
Marcin Ziemniak
Magdalena Ozga
Radosław Borowski
Jarosław Antosik
Angelika Kaczyńska
Beata Pająk
author_sort Marcin Mielecki
collection DOAJ
description Protein aggregation is a well-recognized problem in industrial preparation, including biotherapeutics. These low-energy states constantly compete with a native-like conformation, which is more pronounced in the case of macromolecules of low stability in the solution. A better understanding of the structure and function of such aggregates is generally required for the more rational development of therapeutic proteins, including single-chain fusion cytotoxins to target specific receptors on cancer cells. Here, we identified and purified such particles as side products of the renaturation process of the single-chain fusion cytotoxin, composed of two diphtheria toxin (DT) domains and interleukin 13 (IL-13), and applied various experimental techniques to comprehensively understand their molecular architecture and function. Importantly, we distinguished soluble purified dimeric and fractionated oligomeric particles from aggregates. The oligomers are polydisperse and multimodal, with a distribution favoring lower and even stoichiometries, suggesting they are composed of dimeric building units. Importantly, all these oligomeric particles and the monomer are cystine-dependent as their innate disulfide bonds have structural and functional roles. Their reduction triggers aggregation. Presumably the dimer and lower oligomers represent the metastable state, retaining the native disulfide bond. Although significantly reduced in contrast to the monomer, they preserve some fraction of bioactivity, manifested by their IL-13RA2 receptor affinity and selective cytotoxic potency towards the U-251 glioblastoma cell line. These molecular assemblies probably preserve structural integrity and native-like fold, at least to some extent. As our study demonstrated, the dimeric and oligomeric cytotoxin may be an exciting model protein, introducing a new understanding of its monomeric counterpart’s molecular characteristics.
first_indexed 2024-03-09T04:39:41Z
format Article
id doaj.art-16e5a8f46d36429daa0f92672fe79a37
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-09T04:39:41Z
publishDate 2022-08-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-16e5a8f46d36429daa0f92672fe79a372023-12-03T13:22:50ZengMDPI AGBiomolecules2218-273X2022-08-01128111110.3390/biom12081111Structure–Activity Relationship of the Dimeric and Oligomeric Forms of a Cytotoxic Biotherapeutic Based on Diphtheria ToxinMarcin Mielecki0Marcin Ziemniak1Magdalena Ozga2Radosław Borowski3Jarosław Antosik4Angelika Kaczyńska5Beata Pająk6WPD Pharmaceuticals, Żwirki and Wigury 101, 02-089 Warsaw, PolandWPD Pharmaceuticals, Żwirki and Wigury 101, 02-089 Warsaw, PolandWPD Pharmaceuticals, Żwirki and Wigury 101, 02-089 Warsaw, PolandWPD Pharmaceuticals, Żwirki and Wigury 101, 02-089 Warsaw, PolandWPD Pharmaceuticals, Żwirki and Wigury 101, 02-089 Warsaw, PolandWPD Pharmaceuticals, Żwirki and Wigury 101, 02-089 Warsaw, PolandWPD Pharmaceuticals, Żwirki and Wigury 101, 02-089 Warsaw, PolandProtein aggregation is a well-recognized problem in industrial preparation, including biotherapeutics. These low-energy states constantly compete with a native-like conformation, which is more pronounced in the case of macromolecules of low stability in the solution. A better understanding of the structure and function of such aggregates is generally required for the more rational development of therapeutic proteins, including single-chain fusion cytotoxins to target specific receptors on cancer cells. Here, we identified and purified such particles as side products of the renaturation process of the single-chain fusion cytotoxin, composed of two diphtheria toxin (DT) domains and interleukin 13 (IL-13), and applied various experimental techniques to comprehensively understand their molecular architecture and function. Importantly, we distinguished soluble purified dimeric and fractionated oligomeric particles from aggregates. The oligomers are polydisperse and multimodal, with a distribution favoring lower and even stoichiometries, suggesting they are composed of dimeric building units. Importantly, all these oligomeric particles and the monomer are cystine-dependent as their innate disulfide bonds have structural and functional roles. Their reduction triggers aggregation. Presumably the dimer and lower oligomers represent the metastable state, retaining the native disulfide bond. Although significantly reduced in contrast to the monomer, they preserve some fraction of bioactivity, manifested by their IL-13RA2 receptor affinity and selective cytotoxic potency towards the U-251 glioblastoma cell line. These molecular assemblies probably preserve structural integrity and native-like fold, at least to some extent. As our study demonstrated, the dimeric and oligomeric cytotoxin may be an exciting model protein, introducing a new understanding of its monomeric counterpart’s molecular characteristics.https://www.mdpi.com/2218-273X/12/8/1111biotherapeuticscytotoxindiphtheria toxinIL-13inclusion bodiesrefolding
spellingShingle Marcin Mielecki
Marcin Ziemniak
Magdalena Ozga
Radosław Borowski
Jarosław Antosik
Angelika Kaczyńska
Beata Pająk
Structure–Activity Relationship of the Dimeric and Oligomeric Forms of a Cytotoxic Biotherapeutic Based on Diphtheria Toxin
Biomolecules
biotherapeutics
cytotoxin
diphtheria toxin
IL-13
inclusion bodies
refolding
title Structure–Activity Relationship of the Dimeric and Oligomeric Forms of a Cytotoxic Biotherapeutic Based on Diphtheria Toxin
title_full Structure–Activity Relationship of the Dimeric and Oligomeric Forms of a Cytotoxic Biotherapeutic Based on Diphtheria Toxin
title_fullStr Structure–Activity Relationship of the Dimeric and Oligomeric Forms of a Cytotoxic Biotherapeutic Based on Diphtheria Toxin
title_full_unstemmed Structure–Activity Relationship of the Dimeric and Oligomeric Forms of a Cytotoxic Biotherapeutic Based on Diphtheria Toxin
title_short Structure–Activity Relationship of the Dimeric and Oligomeric Forms of a Cytotoxic Biotherapeutic Based on Diphtheria Toxin
title_sort structure activity relationship of the dimeric and oligomeric forms of a cytotoxic biotherapeutic based on diphtheria toxin
topic biotherapeutics
cytotoxin
diphtheria toxin
IL-13
inclusion bodies
refolding
url https://www.mdpi.com/2218-273X/12/8/1111
work_keys_str_mv AT marcinmielecki structureactivityrelationshipofthedimericandoligomericformsofacytotoxicbiotherapeuticbasedondiphtheriatoxin
AT marcinziemniak structureactivityrelationshipofthedimericandoligomericformsofacytotoxicbiotherapeuticbasedondiphtheriatoxin
AT magdalenaozga structureactivityrelationshipofthedimericandoligomericformsofacytotoxicbiotherapeuticbasedondiphtheriatoxin
AT radosławborowski structureactivityrelationshipofthedimericandoligomericformsofacytotoxicbiotherapeuticbasedondiphtheriatoxin
AT jarosławantosik structureactivityrelationshipofthedimericandoligomericformsofacytotoxicbiotherapeuticbasedondiphtheriatoxin
AT angelikakaczynska structureactivityrelationshipofthedimericandoligomericformsofacytotoxicbiotherapeuticbasedondiphtheriatoxin
AT beatapajak structureactivityrelationshipofthedimericandoligomericformsofacytotoxicbiotherapeuticbasedondiphtheriatoxin